TY - JOUR T1 - Oxyphenbutazone eye ointment JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 88 LP - 88 DO - 10.1136/dtb.22.22.88 VL - 22 IS - 22 A2 - , Y1 - 1984/11/05 UR - http://dtb.bmj.com/content/22/22/88.abstract N2 - We have previously considered oxyphenbutazone eye ointment (Tanderil Eye Ointment).1,2 Recently, the Licensing Authority has withdrawn the product licence for oral oxyphenbutazone because of its bone marrow toxicity.3 Oxyphenbutazone eye ointment is used for treating episcleritis: should its licence also be withdrawn? ER -